This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Glucose-6-Phosphate Dehydrogenase (G-6-PDH)

Starting date:
December 29, 2016
Posting date:
February 9, 2017
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Medical Devices
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-62118

Reason

Trinity Biotech has identified a potential for misdiagnosis with lots F117009 and F229031. A recent investigation has identified that these two lots display a level of accuracy variation outside the historical (quality control) QC product release process control charts for normal range controls, despite falling within the QC acceptance specification.

Affected products

Glucose-6-Phosphate Dehydrogenase (G-6-PDH)

Lot or serial number

F229031

Model or catalog number

345-B

Companies

Manufacturer
Trinity Biotech PLC
IDA Business Park
Bray, Wicklow
IRELAND